/PRNewswire/ ReddyPort, a NIV-focused medical technology company, announced today that US Patent No 11,324,910 has been issued by the US Patent Office.
/PRNewswire/ ReddyPort, a NIV-focused medical technology company, announced today that US Patent No 11,400,248 has been issued by the US Patent Office.
ReddyPort®, a medical technology company focused on bringing new non-invasive ventilation (NIV) products into market, announced today that US Patent No.
Share this article
Share this article
SALT LAKE CITY, Dec. 15, 2020 /PRNewswire/ ReddyPort, a medical technology company focused on bringing non-invasive ventilation (NIV) products into the market, announced it raised Seed Funding to support product launch in 2021. Tony Lair, the former CEO of NeoMed (acquired by Avanos), led the investment round with participation from existing and new investors including Spring Bay Ventures and MedMountain Ventures (MMV). Tony Lair will join ReddyPort s Board of Directors.
Patients on non-invasive ventilation experience dry mouth, phlegm build-up, and the inability to speak and be clearly heard. These unmet needs continue to grow through COVID-19. Removing non-invasive ventilation masks can lead to airway and alveolar collapse